ATM and neoplasm: Blocking ATM-related DNA damage in T cells could prevent T cell aging mediated by tumor-associated factors and Treg cells in vitro, and enhance antitumor immunity and the effectiveness of immunotherapy in vivo in the context of adoptive transfer T cell therapy57.